|
Jul 30, 2012, 08.48 AM IST
Dr Reddy's Laboratories , India's No. 2 drugmaker by sales, said the US drug regulator has lifted a ban on its manufacturing unit in Mexico and that it can start shipping products from the facility to the United States.
The US Food and Drug Administration had issued a warning letter to the company's manufacturing unit at Cuernavaca in June last year saying it had violated manufacturing standards, and stopped shipments to the US. Dr Reddy's said in a statement late on Friday it worked with the regulator to resolve the issues it had raised, after which it received a "clearance" from the USFDA on July 26. The unit in Mexico makes bulk drugs.
Set email alert for |
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
